Latisse Alternatives Compared
| Latisse (bimatoprost) | Bimatoprost topical | Fluorometholone ophthalmic |
|
|---|
| Latisse (bimatoprost) | Bimatoprost topical | Fluorometholone ophthalmic |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Eyelash Hypotrichosis. Latisse may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Eyelash Hypotrichosis. Bimatoprost topical may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Eyelash Hypotrichosis, Steroid Responsive Inflammatory Conditions, Eye Redness/Itching, Allergies, Eye Redness. Fluorometholone ophthalmic may also be used for purposes not listed in... View more |
Related suggestions Eyelash Hypotrichosis
|
|||||||||||||||||||||||
| More about Latisse (bimatoprost) | More about Bimatoprost topical | More about Fluorometholone ophthalmic | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Latisse has an average rating of 8.8 out of 10 from a total of 4 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
Bimatoprost topical has an average rating of 8.8 out of 10 from a total of 4 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
Fluorometholone ophthalmic has an average rating of 6.3 out of 10 from a total of 11 ratings on Drugs.com. 45% of reviewers reported a positive effect, while 27% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Latisse side effects |
View all Bimatoprost topical side effects |
|||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
Lower cost generic |
|||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Latisse prices |
View all Bimatoprost topical prices |
View all Fluorometholone ophthalmic prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
Latisse | Eflone, Flarex, FML, FML Forte Liquifilm, FML Liquifilm, FML S.O.P. | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
0.75 hours |
0.75 hours |
N/A |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 5 drugs are known to interact with Latisse:
|
A total of 5 drugs are known to interact with Bimatoprost topical:
|
A total of 42 drugs are known to interact with Fluorometholone ophthalmic:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
December 24, 2008 |
N/A |
N/A |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.